Determination and modelling of stereoselective interactions of ligands with drug transporters: A key dimension in the understanding of drug disposition

References

• Aboul-Enein HY, Wainer IW. The Impact of stereochemistry on drug development and use. Wiley, New York, NY 1997
   Google Scholar
• Bednarczyk D, Ekins S, Wikel JH, Wright SH. Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. Molecular Pharmacology 2003; 63: 489–498
   PubMed Web of Science ®Google Scholar
• Beigi F, Chakir K, Xiao R-P, Wainer IW. G-protein coupled receptor chromatographic stationary phases II: Ligand-induced conformational mobility in an immobilized β2-adrenergic receptor. Analysis of Chemistry 2004; 76: 7187–7194
   PubMed Web of Science ®Google Scholar
• Booth TD, Wainer IW. Investigation of the enantioselective separations of α-arylcarboxylic acids on an amylose tris(3,5-dimethylphenylcarbamate) chiral stationary phase using quantitative structure–enantioselective retention relationships: Identification of a conformationally driven chiral recognition mechanism. Journal of Chromatography A 1996; 737: 1657–1169
   Google Scholar
• Casy AF. Stereochemistry and biological activity. Medicinal chemistry3rd, A Burger. Wiley, New York, NY 1970; 81–107
   Google Scholar
• Chang C, Swaan PW. Computational approaches to modeling drug transporters. European Journal of Pharmaceutical Science 2006; 27: 411–424
   PubMed Web of Science ®Google Scholar
• Dey S, Hafkemeyer P, Pastan I, Gottesman MM. A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopaine receptor antagonist flupentixol. Biochemistry 1999; 38: 6630–6639
   PubMed Web of Science ®Google Scholar
• Drayer DE. The early history of stereochemistry: From the discovery of molecular asymmetry and the first resolution of a racemate to the asymmetrical chiral carbon of van’t Hoff and Le Bel. Drug stereochemistry: Analytical methods and pharmacology2nd, IW Wainer. Marcel Dekker, New York, NY 1993; 1–24
   Google Scholar
• Ekins S, Ecker GF, Chiba P, Swann PW. Future directions for drug transporter modelling. Xenobiotica 2007; 37: 1152–1170
   PubMed Web of Science ®Google Scholar
• Ekins S, Kim RB, Leake BF, Dantzig AH, Schuetz EG, Lan L, Yasuda K, Shepard RL, Winter MA, Schuetz JD, et al. Three-dimensional quantitative structure–activity relationships of inhibitors of P-glycoprotein. Molecular Pharmacology 2002a; 61: 964–973
   PubMed Web of Science ®Google Scholar
• Ekins S, Kim RB, Leake BF, Dantzig AH, Schuetz EG, Lan L, Yasuda K, Shepard RL, Winter MA, Schuetz JD, et al. Application of three-dimensional quantitative structure–activity relationships of P-glycoprotein inhibitors and substrates. Molecular Pharmacology 2002b; 61: 974–981
   PubMed Web of Science ®Google Scholar
• Fisher GA, Sikic BI. Clinical studies with modulators of multidrug resistance. Hematology and Oncology Clinics of North America 1995; 9: 363–382
   PubMed Web of Science ®Google Scholar
• Ford JM, Prozialeck WC, Hait WN. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance. Molecular Pharmacology 1989; 35: 105–115
   PubMed Web of Science ®Google Scholar
• Gruber A, Peterson C, Reizenstein P. D-verapamil and L-verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro. International Journal of Cancer 1988; 41: 224–226
   PubMed Web of Science ®Google Scholar
• Hagglund CL, Lundahl P. Centrifugal and chromatographic analyses of tryptophan and tyrosine uptake by red blood cells and LGUT1 proteoliposomes with permeability estimates and observations on dihydrocytochalasin. British Journal of Biochemical and Biophysical Methods 2003; 55: 127–140
   PubMedGoogle Scholar
• Hollt V, Kouba M, Dietel M, Vogt G. Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by p-glycoprotein. Biochemistry and Pharmacology 1992; 43: 2601–2608
   PubMed Web of Science ®Google Scholar
• Hooiveld GJEJ, Heegsma J, Van Montfoort JE, Jansen PLM, Meijer DKF, Muller M. Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins. British Journal of Pharmacology 2002; 135: 1685–1694
   PubMed Web of Science ®Google Scholar
• Jozwiak J, Ravichandran R, Collins JR, Wainer IW. The interaction of non-competitive inhibitors alpha3beta4 nicotinic acetylcholine receptor investigated by affinity chromatography, QSAR and molecular docking. Journal of Medicine and Chemistry 2004; 47: 4008–4021
   PubMed Web of Science ®Google Scholar
• Jozwiak K, Ravichandran S, Collins JR, Moaddel R, Wainer IW. Interaction of noncompetitive inhibitors the α3β2 nicotinic acetylcholine receptor investigated by affinity chromatography and molecular docking. Journal of Medicine and Chemistry 2007; 50: 6279–6283
   PubMedGoogle Scholar
• Kimura T, Perry J, Anzai N, Pritchard J, Moaddel R. Development and characterization of immobilized human organic anion transporter based liquid chromatographic stationary phase: hOAT1 and hOAT2. Journal of Chromatography B 2007; 859: 267–271
   PubMedGoogle Scholar
• Koepsell H, Schmitt BM, Gorboulev V. Organic cation transporters. Reviews in Physics, Biochemistry and Pharmacology 2003; 150: 36–90
   PubMed Web of Science ®Google Scholar
• Langaniere S. Current regulatory guidelines of stereoisomeric drugs: North American, European and Japanese point of view. The impact of stereochemistry on drug development and use, HY Aboul-Enein, IW Wainer. Wiley, New York, NY 1997; 545–564
   Google Scholar
• Leonessa F, Green D, Licht T, Wright A, Wingate-Legette K, Lippman J, Gottesman MM, Clarke R. MDA435/LCC6 and MDA435/LCC435MDR1: Ascities models of human breast cancer. British Journal of Cancer 1996; 73: 154–161
   PubMed Web of Science ®Google Scholar
• Leslie EM, Deeley RG, Cole SPC. Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicology and Applied Pharmacology 2005; 204: 216–237
   PubMed Web of Science ®Google Scholar
• Longstreth JA. Verapamil: A chiral challenge to the pharmacokinetic and pharmacodynamic assessment of bioavailability and bioequivalence. Drug stereochemistry: Analytical methods and pharmacology2nd, IW Wainer. Marcel Dekker, New York, NY 1993; 315–335
   Google Scholar
• Lu L, Leonessa F, Baynham MT, Clarke R, Gimenez F, Pham YT, Roux F, Wainer IW. The enantioselective binding of mefloquine enantiomers to P-glycoprotein determined using an immobilized P-glycoprotein liquid chromatographic stationary phase. Pharmacology Research 2001b; 18: 1327–1329
   PubMedGoogle Scholar
• Lu L, Leonessa F, Clarke R, Wainer IW. Competitive and allosteric interactions in ligand binding to P-glycoprotein as observed on an immobilized P-glycoprotein liquid chromatographic stationary phase. Molecular Pharmacology 2001a; 59: 62–68
   PubMed Web of Science ®Google Scholar
• Moaddel R, Calleri E, Massolini G, Frazier CR, Wainer IW. The synthesis and initial characterization of an immobilized purinergic receptor (P2Y1) liquid chromatography stationary phase for online screening. Annals of Biochemistry 2007b; 364: 216–218
   Google Scholar
• Moaddel R, Jozwiak K, Wainer IW. Allosteric modifiers of neuronal nicotinic acetylcholine receptors: New methods, new opportunities. Medicine Research Review 2007a; 27: 713–753
   Google Scholar
• Moaddel R, Patel S, Jozwiak K, Yamaguchi R, Ho PC, Wainer IW. Enantioselective binding to the human organic cation transporter-1 (hOCT1) determined using an immobilized hOCT1 liquid chromatographic stationary phase. Chiralty 2005a; 17: 501–506
   PubMedGoogle Scholar
• Moaddel R, Ravichandran S, Bighi F, Yamaguchi R, Wainer IW. Pharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1). British Journal of Pharmacology 2007c; 151: 1305–1314
   PubMed Web of Science ®Google Scholar
• Moaddel R, Wainer IW. Development of immobilized membrane-based affinity columns for use in the online characterization of membrane bound proteins and for targeted affinity isolations. Analytica Chimica Acta 2006; 564: 97–105
   PubMedGoogle Scholar
• Moaddel R, Yamaguchi R, Ho PC, Patel S, Hsu CP, Subrahmanyam V, Wainer IW. Development and characterization of an immobilized human organic cation transporter based liquid chromatographic stationary phase. Journal of Chromatography B 2005b; 818: 263–268
   PubMedGoogle Scholar
• Moaddel R, Hamid R, Patel S, Bullock P, Wainer IW. Identification of P-glycoprotein substrates using open tubular chromatography on an immobilized P-glycoprotein column: Comparison of chromatographic results with Caco-2 permeability. Analytica Chimica Acta 2006; 578: 25–30
   PubMed Web of Science ®Google Scholar
• Neuhoff S, Langguth P, Dressler C, Andersson TB, Regardh CG, Spahn-Langguth H. Affinities at the verpamil binding site of MDR1-encoded P-glycoprotein: Drugs and analogs, stereoisomers and metabolites. International Journal of Clinical Pharmacology Therapy 2000; 38: 168–179
   PubMedGoogle Scholar
• Pham YT, Regina A, Farinotti R, Couraud PO, Wainer IW, Roux F, Gimenez F. Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochimica et Biophysica Acta 2000; 1524: 212–219
   PubMed Web of Science ®Google Scholar
• Sonveaux N, Shapiro AB, Goormaghtigh E, Ling V, Ruysschaert JM. Secondary and tertiary structure changes of reconstituted P-glycoprotein. A Fourier transform attenuated total reflection infrared spectroscopy analysis. Journal of Biology and Chemistry 1996; 271: 24617–24624
   PubMed Web of Science ®Google Scholar
• Spiegl-Kreinecker S, Buchroithner J, Elbling L, Steiner E, Wurm G, Bodenteich A, Fischer J, Mickshe M, Berger W. Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes. Journal of Neuro-Oncology 2002; 57: 27–36
   PubMed Web of Science ®Google Scholar
• Wagner CA, Lukewille U, Kaltenbach S, Moschen I, Broer A, Risler T, Broer S, Lang F. Functional and pharmacological characterization of the human Na+/carnitine cotransporter hOCTN2. American Journal of Physiology and Renal Physiology 2000; 279: F584–F591
   PubMed Web of Science ®Google Scholar
• Wainer IW. Drug stereochemistry: Analytical methods and pharmacology. 2nd ed. Marcel Dekker, New York, NY 1993
   Google Scholar
• Wainer IW, Marcotte AA. Stereochemical terms and concepts: An overview. Drug stereochemistry: Analytical methods and pharmacology2nd, IW Wainer. Marcel Dekker, New York, NY 1993; 25–34
   Google Scholar
• Wigler PW, Patterson FK. Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts. Biochimica et Biophysica Acta 1994; 1189: 1–6
   PubMed Web of Science ®Google Scholar
• Zhang L, Gorset W, Dresser MJ, Giacomini KM. The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1. Journal of Pharmacology and Experimental Therapy 1999; 288: 1192–1198
   PubMed Web of Science ®Google Scholar
• Zhang L, Schaner ME, Giacomini KM. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). Journal of Pharmacology and Experimental Therapy 1998; 286: 354–361
   PubMed Web of Science ®Google Scholar
• Zhang Y, Leonessa R, Clarke R, Wainer IW. Development of an immobilized P-glycoprotein stationary phase for on-line liquid chromatographic determination of drug binding affinities. Journal of Chromatography B 2000; 739: 33–37
   PubMedGoogle Scholar